Valeant wins approval of eye drug that FDA rejected twice over manufacturing problems
Joseph Papa, who was brought in to clean up the mess at Valeant Pharmaceuticals, has even worked some magic on a Bausch & Lomb manufacturing plant, winning the drugmaker a novel drug approval in the process. The FDA recently approved the company’s long-delayed eye drug latanoprostene bunod ophthalmic solution.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063